Key result
DCD heart transplantation yields similar 1-year mortality to DBD in LVAD patients.
Why the study?
Does heart transplantation using donation after circulatory death (DCD) maintain survival compared to donation after brain death (DBD) in adult patients with a left ventricular assist device (LVAD)?
Cohort (n=3,336)
Yes
Does heart transplantation using donation after circulatory death (DCD) maintain survival compared to donation after brain death (DBD) in adult patients with a left ventricular assist device (LVAD)?
Answers are grounded in this paper and cite their sources.
In LVAD patients, heart transplantation using donation after circulatory death yields similar 1-year survival to donation after brain death and facilitates earlier transplantation, though it is associated with higher rates of primary graft dysfunction and treated rejection.
AIMS: Donation after circulatory death (DCD) has emerged as a strategy to increase the donor pool for heart transplantation (HT). Left ventricular assist device (LVAD) patients represent a discrete and unique population. We sought to explore the early outcomes of DCD-HT compared with donation after brain death (DBD) HT in LVAD patients. METHODS AND RESULTS: We obtained data from the United Network of Organ Sharing database. The main cohort consisted of adults listed for HT between 17 October 2018 and 3 July 2024, with LVAD implanted before or after listing. The primary outcome was survival within the first year post-HT. There were 3336 patients with LVAD underwent HT during the study period (median age 55 years (interquartile range 45-62), 24% women, 29% Black, 89% DBD). The short-term post-HT mortality in LVAD patients who underwent DCD HT was not significantly different from DBD (adjusted hazard ratio [aHR] 1.00, 95% CI 0.70-1.42, P value > 0.9). The likelihood of transplantation within 1 year was higher at centres performing DCD (aHR 1.44, 95% CI 1.39-1.49, P < 0.001). Despite the longer donor-recipient distance in DCD-HT, in-hospital outcomes (stroke and acute kidney injury requiring dialysis) were not different from DBD-HT. A higher incidence of primary graft dysfunction (adjusted risk ratio [aRR] 3.8, 95% CI 2.5-5.7, P < 0.001), and treated rejection was observed with DCD-HT (aRR 1.48, 95% CI 1.14-1.93, P = 0.003). CONCLUSIONS: In LVAD patients who received DCD HT, early post-transplant survival, stroke, acute kidney injury and length of stay were not significantly different from those who underwent DBD HT. There were increased rates of primary graft dysfunction and treated rejection among LVAD patients who underwent DCD HT. Patients in a DCD centre were significantly more likely to be transplanted earlier.
No takes yet. Share an insight, caveat, or question.
Karatasakis et al. (2025) conducted a cohort in Left ventricular assist device (LVAD) patients requiring heart transplantation (n=3,336). Donation after circulatory death (DCD) heart transplantation vs. Donation after brain death (DBD) heart transplantation was evaluated on Survival within the first year post-HT (aHR 1.00, 95% CI 0.70-1.42, p=> 0.9). Heart transplantation using donation after circulatory death in LVAD patients was associated with similar 1-year mortality compared to donation after brain death.
Synapse has enriched 10 related papers. Consider them for comparative context: